SOON.SW
Sonova Holding AG

Healthcare · Medical Devices · valued as of 2026-11-03 · statements 2026-03-31

Average Intrinsic Value

6.31B USD

Market Cap

17.92B USD

Margin of Safety

-184.0%

Intrinsic / Market Ratio

0.35×

Projections, not exact values. Intrinsic Values are projected from each company's past reports. They show which stocks look cheap compared with the others, not exactly what a stock is worth.

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

6.52B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

7.36B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

5.05B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

6.31B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

6.31B USD

from the sum above

Market Cap

17.92B USD

the price on the date above times the shares

Intrinsic Value ÷ Market Cap

0.35×

the ratio the screener ranks by; Margin of Safety -184.0% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 6.52B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)7.60B USD
−②Net Debt Today1.24B USD
+③Growth Value156.75M USD
=Value6.52B USD

EPV of the Operations (NOPAT over WACC)

7.60B USD

Net debt today

-1.24B USD

Growth Value

+156.75M USD

Value

6.52B USD

①EPV (earnings power value)

7.60B USD

②Net Debt Today

1.24B USD

③Growth Value

156.75M USD

Market value

Market Cap17.92B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-174.9%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 7.36B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE5.59B USD
+②Equity at Year 15, Today1.76B USD
=Value7.36B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

5.59B USD

②Equity at Year 15, Today

1.76B USD

Market value

Market Cap17.92B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-143.6%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 5.05B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF5.06B USD
+②Invested Capital at Year 15, Today1.24B USD
−③Net Debt Today1.24B USD
=Value5.05B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth rising to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

5.06B USD

②Invested Capital at Year 15, Today

1.24B USD

③Net Debt Today

1.24B USD

Market value

Market Cap17.92B USD

The price on the date above times the shares.

Value vs market

Margin of Safety-254.7%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 10.12%
Cost of Equity =Risk-Free Rate 4.50%+Beta 1.11×Market Risk Premium 6.00%= 11.16%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 119.76M USDPretax Income 803.05M USD= 14.91%

The tax the interest saves.

Interest Expense =EBIT 838.96M USD−Pretax Income 803.05M USD= 35.92M USD

The interest the company paid: EBIT is the profit before tax plus the interest.

Cost of Debt =Interest Expense 35.92M USDTotal Debt 2.14B USD×(1 − Tax Rate for WACC 14.91%)= 1.43%

What the lenders are paid a year after the tax the interest saves.

Debt Weight =Total Debt 2.14B USDMarket Cap + Total Debt 17.92B USD + 2.14B USD= 10.68%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 89.32%×Cost of Equity 11.16%+Debt Weight 10.68%×Cost of Debt 1.43%= 10.12%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-03-31.

Total Assets 7.04B USD − Total Liabilities 3.75B USD = Book Value Today 3.30B USD

Total Debt 2.14B USD − Cash and Short-Term Investments 903.66M USD = Net Debt Today 1.24B USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 1-0.3%at most 5%passes59,404,602 / 59,613,222
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets5.4%at least -10.0%passes(919.18M USD − 538.87M USD) ÷ 7.04B USD
Price to bookMarket Cap ÷ Book Value Today5.43×at most 3×does not pass17.92B USD ÷ 3.30B USD
Operating marginOperating Income ÷ Revenue18.7%above 10.0%passes845.85M USD ÷ 4.51B USD
Revenue growthRevenue ÷ Revenue a Year Before − 19.9%above 10.0%does not pass4.51B USD / 4.11B USD
Net cash(Cash − Total Debt) ÷ Market Cap-6.9%above -30%passes(903.54M USD − 2.14B USD) ÷ 17.92B USD
Operating efficiencyOperating Income ÷ Gross Profit25.4%above 25.0%passes845.85M USD ÷ 3.33B USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Share price

248.65 CHF

Enterprise value

15.89B CHF

the provider's own figure

EV / EBITDA

18.86×

Price / book

5.65×

the provider's book

Price / earnings

27.57×

Return on equity

20.5%

the provider's figure, not this page's

Profit margin

11.9%

Revenue growth

—

Analyst target, mean

235.92 CHF

Analysts

19

opinions in the consensus

Financial Statements

The annual lines the screener holds, year by year, in USD at each period's rate; the figures this valuation read are in its calculation above.

USD2023202420252026
Income statement

Revenue

4.10B4.03B4.11B4.51B

Gross profit

2.89B2.90B3.05B3.33B

Operating income

818.44M744.19M817.98M845.85M

EBITDA

operating income before depreciation and amortisation

1.07B1.02B1.07B1.16B

Pretax income

784.25M719.09M777.64M803.05M

Net income

709.61M667.65M614.23M538.87M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

709.61M667.65M634.57M672.15M

R&D

268.06M265.51M243.53M272.44M
Balance sheet, year end

Total assets

6.09B6.43B6.73B7.04B

Total liabilities

3.64B3.67B3.68B3.75B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

2.42B2.74B3.03B3.27B

Total debt

1.99B1.99B2.00B2.14B

Cash and equivalents

453.61M570.56M780.59M903.54M

Net PP&E

fixed assets after depreciation

722.88M722.09M701.96M741.48M

Working capital

current assets less current liabilities

447.91M571.56M467.29M1.12B
Cash flow

Operating cash flow

859.10M836.84M898.10M919.18M

Capital expenditure

paid out, so below zero

-169.10M-142.86M-149.66M-128.52M

Depreciation and amortisation

262.69M273.50M264.33M325.75M

Free cash flow

operating cash flow plus capital expenditure

690.00M693.98M748.43M790.66M